Targeted therapies in bladder cancer: signaling pathways, applications, and challenges

Abstract Bladder cancer (BC) is one of the most prevalent malignancies in men. Understanding molecular characteristics via studying signaling pathways has made tremendous breakthroughs in BC therapies. Thus, targeted therapies including immune checkpoint inhibitors (ICIs), antibody–drug conjugates (...

Full description

Bibliographic Details
Published in:MedComm
Main Authors: Mei Peng, Xuetong Chu, Yan Peng, Duo Li, Zhirong Zhang, Weifan Wang, Xiaochen Zhou, Di Xiao, Xiaoping Yang
Format: Article
Language:English
Published: Wiley 2023-12-01
Subjects:
ADCs
bladder cancer
CSCs
ICIs
metabolism
TKIs
Online Access:https://doi.org/10.1002/mco2.455

Internet

https://doi.org/10.1002/mco2.455

Similar Items